Patient Representative Volunteer Role – Genitourinary Disease Site Committee
Where: Canadian Cancer Trials Group (CCTG)
Description: The Canadian Cancer Trials Group (CCTG) is currently seeking applications for a Patient Representative for the Genitourinary Disease Site Committee. CCTG is an inclusive organization dedicated to building a diverse network.
This is a volunteer role for membership on the Genitourinary Disease Site Committee, the Genitourinary Disease Site Executive Committee, and the CCTG Patient Representative Committee. Patient Representatives participate in all aspects of their Site Committee activities, and collectively all Site Committee Patient Representatives make up the CCTG Patient Representative Committee.
The role of Patient Representatives at CCTG is to represent the perspective of patients and their families, and the public at large, in the development and delivery of clinical trials. The goal is to team with health care professionals/researchers to advance outstanding research in the treatment, care, and prevention of cancer to improve patient outcomes by assisting in identifying patient priorities, outcomes that are important to patients, and patient barriers.
The CCTG conducts the entire range of trials from early phase (e.g., phase I-II) studies to large international randomized controlled (e.g., phase III) trials across all cancer types. Its primary mission is to assess the effectiveness of interventions to prevent the development of cancer or improve the treatment and care of those patients who do develop cancer.
Patient Representative Volunteer Role – Gynecology Disease Site Committee
Where: Canadian Cancer Trials Group (CCTG)
Description: The Canadian Cancer Trials Group (CCTG) is currently seeking applications for a Patient Representative for the Hematology Disease Site Committee. CCTG is an inclusive organization dedicated to building a diverse network. We encourage applications from all qualified candidates and will accommodate applicants’ needs throughout all stages of the recruitment and selection process.
This is a volunteer role for membership on the Gynecology Disease Site Committee, the Gynecology Disease Site Executive Committee, and the CCTG Patient Representative Committee. Patient Representatives participate in all aspects of their Site Committee activities, and collectively all Site Committee Patient Representatives make up the CCTG Patient Representative Committee.
The role of Patient Representatives at CCTG is to represent the perspective of patients and their families, and the public at large, in the development and delivery of clinical trials. The goal is to team with health care professionals/researchers to advance outstanding research in the treatment, care, and prevention of cancer to improve patient outcomes by assisting in identifying patient priorities, outcomes that are important to patients, and patient barriers.
The CCTG conducts the entire range of trials from early phase (e.g., phase I-II) studies to large international randomized controlled (e.g., phase III) trials across all cancer types. Its primary mission is to assess the effectiveness of interventions to prevent the development of cancer or improve the treatment and care of those patients who do develop cancer.
Patient Representative Volunteer Role – Hematology Disease Site Committee
Where: Canadian Cancer Trials Group (CCTG)
Description: The Canadian Cancer Trials Group (CCTG) is currently seeking applications for a Patient Representative for the Hematology Disease Site Committee. CCTG is an inclusive organization dedicated to building a diverse network. We encourage applications from all qualified candidates and will accommodate applicants’ needs throughout all stages of the recruitment and selection process.
This is a volunteer role for membership on the Hematology Disease Site Committee, the Hematology Disease Site Executive Committee, and the CCTG Patient Representative Committee. Patient Representatives participate in all aspects of their Site Committee activities, and collectively all Site Committee Patient Representatives make up the CCTG Patient Representative Committee.
The role of Patient Representatives at CCTG is to represent the perspective of patients and their families, and the public at large, in the development and delivery of clinical trials. The goal is to team with health care professionals/researchers to advance outstanding research in the treatment, care, and prevention of cancer to improve patient outcomes by assisting in identifying patient priorities, outcomes that are important to patients, and patient barriers.
The CCTG conducts the entire range of trials from early phase (e.g., phase I-II) studies to large international randomized controlled (e.g., phase III) trials across all cancer types. Its primary mission is to assess the effectiveness of interventions to prevent the development of cancer or improve the treatment and care of those patients who do develop cancer.
Patient Representative Volunteer Role – Breast Disease Site Committee
Where: Canadian Cancer Trials Group (CCTG)
Description: The Canadian Cancer Trials Group (CCTG) is currently seeking applications for a Patient Representative for the Breast Disease Site Committee. CCTG is an inclusive organization dedicated to building a diverse network.
This is a volunteer role for membership on the Breast Disease Site Committee, the Breast Disease Site Executive Committee, and the CCTG Patient Representative Committee. Patient Representatives participate in all aspects of their Site Committee activities, and collectively all Site Committee Patient Representatives make up the CCTG Patient Representative Committee.
The role of Patient Representatives at CCTG is to represent the perspective of patients and their families, and the public at large, in the development and delivery of clinical trials. The goal is to team with health care professionals/researchers to advance outstanding research in the treatment, care, and prevention of cancer to improve patient outcomes by assisting in identifying patient priorities, outcomes that are important to patients, and patient barriers.
The CCTG conducts the entire range of trials from early phase (e.g., phase I-II) studies to large international randomized controlled (e.g., phase III) trials across all cancer types. Its primary mission is to assess the effectiveness of interventions to prevent the development of cancer or improve the treatment and care of those patients who do develop cancer.